Barriers and Enablers Affecting the Uptake of Biosimilar Medicines Viewed Through the Lens of Actor Network Theory: A Systematic Review
Abstract Background and Objective Biosimilars represent an opportunity to realise savings
against the costs of innovative medicines. Despite efforts made by stakeholders, there are …
against the costs of innovative medicines. Despite efforts made by stakeholders, there are …
Cost-effectiveness analysis of biologic sequential treatments for moderate-to-severe psoriasis: A Malaysian healthcare system perspective
Objective In Malaysia, there is now a dearth of recommendations pertaining to the priority of
biologic treatments for the effective management of psoriasis, given the multitude of …
biologic treatments for the effective management of psoriasis, given the multitude of …
Biosimilar drug lag and evolution in Malaysia: A retrospective analysis of regulatory approvals
NTM Hoang, O Fatokun, MJ Farrukh - Journal of Applied …, 2025 - japsonline.com
The availability of biosimilars has the potential to increase patient access to affordable
biological treatments. However, a delay in national regulatory approval after global approval …
biological treatments. However, a delay in national regulatory approval after global approval …
[PDF][PDF] Sustainability and Resilience in the Malaysian Health System
SK Khor, EPW Chua, C Fried - 2024 - weforum.org
This report was produced by CAPRI, a nongovernmental, nonpartisan, international
organization committed to enhancing global resilience and promoting innovative …
organization committed to enhancing global resilience and promoting innovative …